EcoR1 Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001587114

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 49 positions · Total reported value $2.40B · Top-10 concentration 72.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 9 new · 5 cut · 7 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.8% · vs SPY +18.0% · Prev Value $2.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, EcoR1 Capital, LLC disclosed 49 equity positions with a combined reported value of $2.40B. The filing implies a focused portfolio: its ten largest positions account for 72.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were PRTA ($558.94M), MRTX ($250.40M), LKFT ($198.88M). By sector, the heaviest allocations are Health Care 67.2%, Materials 0.0%.

Versus the prior quarter, EcoR1 Capital, LLC opened 9 new positions, trimmed 5 and fully exited 7, a turnover rate of 55.3% of positions.

The largest new positions opened in Q3 2023 were PRTA ($558.94M), MRTX ($250.40M), LKFT ($198.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • PRTA PROTHENA CORP PLC · $558.94M
  • MRTX MIRATI THERAPEUTICS INC · $250.40M
  • LKFT LAKEFRONT BIOTHERAPEUTICS NV · $198.88M
  • ANAB ANAPTYSBIO INC · $135.08M
  • ACAD ACADIA PHARMACEUTICALS INC · $124.86M
  • ARVN ARVINAS INC · $107.37M
  • XNCR XENCOR INC COM · $106.44M
  • TNGX TANGO THERAPEUTICS INC · $98.21M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest EcoR1 Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-07 Buy Atara Biotherapeutics, Inc. 507,407 $9.35 SEC filing
2026-04-20 Sell First Tracks Biotherapeutics, Inc. 4,705,575 $13.81 SEC filing

All insider transactions →

Fund Profile

EcoR1 Capital, LLC, based in San Francisco, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 31 positions worth $1.95B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-100470 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $3.42B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds

Portfolio Structure

  • 31 positions · $1.95B reported value (Q2 2026)
  • Top 10 holdings = 87.7% of reported value
  • Largest position: ZYME (ZYMEWORKS INC) at 30.8%
  • Average position size: $62.85M

Sector Tilt

  • Health Care 97.3%
  • Financials 0.1%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 9 new, 2 added, 5 reduced, 7 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 67.2%
Materials 0.0%
Other 32.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 11.58M $558.94M 23.33%
23.33%
New
2 5.75M $250.40M 10.45%
10.45%
New
3 5.76M $198.88M 8.30%
8.30%
New
4 7.52M $135.08M 5.64%
5.64%
New
5 5.99M $124.86M 5.21%
5.21%
New
6 5.47M $107.37M 4.48%
4.48%
New
7 5.28M $106.44M 4.44%
4.44%
New
8 8.72M $98.21M 4.10%
4.10%
New
9 13.44M $85.19M 3.56%
3.56%
New
10 3.46M $80.00M 3.34%
3.34%
New
11 5.81M $52.96M 2.21%
2.21%
New
12 368.41K $47.69M 1.99%
1.99%
New
13 1.53M $45.51M 1.90%
1.90%
New
14 5.62M $36.35M 1.52%
1.52%
New
15 4.16M $35.02M 1.46%
1.46%
New
16 1.48M $33.91M 1.42%
1.42%
New
17 3.85M $29.85M 1.25%
1.25%
New
18 2.07M $29.23M 1.22%
1.22%
New
19 732.50K $27.86M 1.16%
1.16%
New
20 4.06M $26.29M 1.10%
1.10%
New
21 19.21M $25.74M 1.07%
1.07%
New
22 19.36M $24.59M 1.03%
1.03%
New
23 6.12M $23.49M 0.98%
0.98%
New
24 8.54M $21.18M 0.88%
0.88%
New
25 7.00M $20.99M 0.88%
0.88%
New
26 3.42M $20.68M 0.86%
0.86%
New
27 3.49M $20.02M 0.84%
0.84%
New
28 2.98M $19.06M 0.80%
0.80%
New
29 1.40M $14.26M 0.59%
0.59%
New
30 4.49M $14.23M 0.59%
0.59%
New
31 5.00M $12.80M 0.53%
0.53%
New
32 993.00K $12.63M 0.53%
0.53%
New
33 2.05M $7.76M 0.32%
0.32%
New
34 9.20M $7.66M 0.32%
0.32%
New
35 700.00K $7.26M 0.30%
0.30%
New
36 6.44M $6.89M 0.29%
0.29%
New
37 600.00K $5.72M 0.24%
0.24%
New
38 2.98M $3.87M 0.16%
0.16%
New
39 1.16M $3.58M 0.15%
0.15%
New
40 3.95M $2.95M 0.12%
0.12%
New
41 4.60M $2.83M 0.12%
0.12%
New
42 200.00K $2.45M 0.10%
0.10%
New
43 748.90K $1.70M 0.07%
0.07%
New
44 963.33K $1.29M 0.05%
0.05%
New
45 31.30K $866.38K 0.04%
0.04%
New
46 66.67K $616.65K 0.03%
0.03%
New
47 931.00K $283.68K 0.01%
0.01%
New
48 100.00K $212.00K 0.01%
0.01%
New
49 66.67K $32.67K 0.00%
0.00%
New

FAQ

What did EcoR1 Capital, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, EcoR1 Capital, LLC reported 49 equity positions worth $2.40B in aggregate; its largest disclosed positions were PRTA ($558.94M), MRTX ($250.40M), LKFT ($198.88M).

How large is EcoR1 Capital, LLC's portfolio?

EcoR1 Capital, LLC reported $2.40B of long equity holdings across 49 positions as of 2023-Q3. Top-10 holdings account for 72.9% of reported value.

What is EcoR1 Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ecor1-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →